Suppr超能文献

相似文献

2
A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis.
Oncogene. 2009 Dec 3;28(48):4237-48. doi: 10.1038/onc.2009.272. Epub 2009 Sep 7.
9
Macrophage-tumor cell fusions from peripheral blood of melanoma patients.
PLoS One. 2015 Aug 12;10(8):e0134320. doi: 10.1371/journal.pone.0134320. eCollection 2015.
10
Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.
Am J Pathol. 2006 Aug;169(2):643-54. doi: 10.2353/ajpath.2006.051041.

引用本文的文献

1
What are the therapeutic implications of increased collagen expression in melanoma cells treated with vemurafenib?
Melanoma Manag. 2016 Mar;3(1):5-8. doi: 10.2217/mmt.15.36. Epub 2016 Feb 18.
2
Intratumor and Intertumor Heterogeneity in Melanoma.
Transl Oncol. 2017 Dec;10(6):956-975. doi: 10.1016/j.tranon.2017.09.007. Epub 2017 Oct 24.
3
A slow-cycling subpopulation of melanoma cells with highly invasive properties.
Oncogene. 2018 Jan 18;37(3):302-312. doi: 10.1038/onc.2017.341. Epub 2017 Sep 18.
4
Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?
J Cell Physiol. 2017 Oct;232(10):2674-2678. doi: 10.1002/jcp.25796. Epub 2017 Mar 6.
5
The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
Matrix Biol. 2015 Oct;48:66-77. doi: 10.1016/j.matbio.2015.05.007. Epub 2015 May 16.
6
CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity.
PLoS One. 2015 Mar 23;10(3):e0121140. doi: 10.1371/journal.pone.0121140. eCollection 2015.
7
BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity.
Br J Cancer. 2014 Oct 14;111(8):1625-33. doi: 10.1038/bjc.2014.452. Epub 2014 Aug 12.
8
Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032.
Pigment Cell Melanoma Res. 2014 May;27(3):495-501. doi: 10.1111/pcmr.12220. Epub 2014 Mar 6.
9
Heterogeneity of gene expression in murine squamous cell carcinoma development-the same tumor by different means.
PLoS One. 2013;8(3):e57748. doi: 10.1371/journal.pone.0057748. Epub 2013 Mar 18.

本文引用的文献

2
Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
Oncogene. 2011 May 19;30(20):2307-18. doi: 10.1038/onc.2010.598. Epub 2011 Jan 31.
3
VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.
Cancer Res. 2011 Feb 15;71(4):1474-85. doi: 10.1158/0008-5472.CAN-10-1660. Epub 2011 Jan 6.
5
Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.
Semin Cancer Biol. 2011 Apr;21(2):83-8. doi: 10.1016/j.semcancer.2010.12.007. Epub 2010 Dec 13.
6
Cancer stem cells versus phenotype-switching in melanoma.
Pigment Cell Melanoma Res. 2010 Dec;23(6):746-59. doi: 10.1111/j.1755-148X.2010.00757.x. Epub 2010 Aug 20.
7
IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines.
Int J Cancer. 2011 Jun 15;128(12):2803-14. doi: 10.1002/ijc.25621. Epub 2010 Nov 12.
8
A role for the JARID1B stem cell marker for continuous melanoma growth.
Pigment Cell Melanoma Res. 2010 Aug;23(4):481-3. doi: 10.1111/j.1755-148X.2010.00726.x. Epub 2010 Jun 9.
10
Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells.
J Invest Dermatol. 2010 Jul;130(7):1877-86. doi: 10.1038/jid.2010.69. Epub 2010 Apr 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验